Prevalence of chronic atrophic gastritis in different parts of the world

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 6, 2006, Pages 1083-1094

  Weck, Melanie Nicole ^a   Brenner, Hermann ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PEPSINOGEN;

ADOLESCENT; ADULT; AGED; ATROPHIC GASTRITIS; CHRONIC GASTRITIS; CONTROLLED STUDY; FEMALE; GASTROSCOPY; GEOGRAPHIC DISTRIBUTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SHORT SURVEY;

ADOLESCENT; ADULT; AGED; CHRONIC DISEASE; ENDOSCOPY, GASTROINTESTINAL; FEMALE; GASTRITIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PEPSINOGEN A; PREVALENCE;

EID: 33745683860     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-05-0931     Document Type: Short Survey

References (99)

1. Ferlay JB, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer incidence, mortality and prevalence worldwide. IARC CancerBase No. 5, version 2.0 (htrp://www-depiarcfr/). Lyon: IARC Press; 2004.
2. Correa P. A human model of gastric carcinogenesis. Cancer Res 1988;48:3554-60.
3. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 1992;52:6735-40.
4. Satoh K, Kimura K, Sipponen P. Helicobacter pylori infection and chronological extension of atrophic gastritis. Eur J Gastroenterol Hepatol 1995;7 Suppl 1:811-5.
5. Rugge M, Cassaro M, Leandro G, et al. Helicobacter pylori in promotion of gastric carcinogenesis. Dig Dis Sci 1996;41:950-5.
6. Parsonnet J, Samloff IM, Nelson LM, Orentreich N, Vogelman JH, Friedman GD. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev 1993;2:461-6.
7. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer? Am J Epidemiol 2004;159:252-8.
8. Sipponen P. Update on the pathologic approach to the diagnosis of gastritis, gastric atrophy, and Helicobacter pylori and its sequelae. J Clin Gastroenterol 2001;32:196-202.
9. Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI. Relationships among serum pepsinogen I, serum pepsinogen II, gastric mucosal histology. A study in relatives of patients with pernicious anemia. Gastroenterology 1982;83:204-9.
10. Dinis-Ribeiro M, Yamaki G, Miki K, Costa-Pereira A, Matsukawa M, Kurihara M. Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening. J Med Screen 2004;11:141-7.
11. Siurala M, Isokoski M, Varis K, Kekki M. Prevalence of gastritis in a rural population. Bioptic study of subjects selected at random. Scand J Gastroenterol 1968;3:211-23.
12. Villako K, Tamm A, Savisaar E, Ruttas M. Prevalence of antral and fundic gastritis in a randomly selected group of an Estonian rural population. Scand J Gastroenterol 1976;11:817-22.
13. Kreuning J, Bosman FT, Kuiper G, Wal AM, Lindeman J. Gastric and duodenal mucosa in 'healthy' individuals. An endoscopic and histopathological study of 50 volunteers. J Clin Pathol 1978;31:69-77.
14. Ihamaki T, Varis K, Siurala M. Morphological, functional and immunological state of the gastric mucosa in gastric carcinoma families. Comparison with a computer-matched family sample. Scand J Gastroenterol 1979;14:801-12.
15. Cheli R, Simon L, Aste H, et al. Atrophic gastritis and intestinal metaplasia in asymptomatic Hungarian and Italian populations. Endoscopy 1980;12:105-8.
16. Villako K, Kekki M, Tamm A, et al. Epidemiology and dynamics of gastritis in a representative sample of an Estonin urban population. Scand J Gastroenterol 1982;17:601-7.
17. Villako K, Maards H, Tammur R, et al. Helicobacter (Campylobacter) pylori infestation and the development and progression of chronic gastritis: results of long-term follow-up examinations of a random sample. Endoscopy 1990;22:114-7.
18. Cheli R, Giacosa A. Duodenal ulcer and chronic gastritis. Endoscopy 1986;18:125-6.
19. Correa P, Haenszel W, Cuello C, et al. Gastric precancerous process in a high risk population: cross-sectional studies. Cancer Res 1990;50:4731-6.
20. Johnsen R, Bernersen B, Straume B, Forde OH, Bostad L, Burhol PG. Prevalences of endoscopic and histological findings in subjects with and without dyspepsia. BMJ 1991;302:749-52.
21. Bernersen B, Johnsen R, Straume B, Burhol PG, Jenssen TG, Stakkevold PA. Towards a true prevalence of peptic ulcer: the Sorreisa gastrointestinal disorder study. Gut 1990;31:989-92.
22. You WC, Blot WJ, Li JY, et al. Precancerous gastric lesions in a population at high risk of stomach cancer. Cancer Res 1993;53:1317-21.
23. You WC, Blot WJ, Zhang L, et al. Serum pepsinogens in relation to precancerous gastric lesions in a population at high risk for gastric cancer. Cancer Epidemiol Biomarkers Prev 1993;2:113-7.
24. Katelaris PH, Seow F, Lin BP, Napoli J, Ngu MC, Jones DB. Effect of age, Helicobacter pylori infection, and gastritis with atrophy on serum gastrin and gastric acid secretion in healthy men. Gut 1993;34:1032-7.
25. Asaka M, Kato M, Kudo M, et al. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults. Helicobacter 1996;1:52-6.
26. You WC, Zhang L, Gail MH, et al. Precancerous lesions in two counties of China with contrasting gastric cancer risk. Int J Epidemiol 1998;27:945-8.
27. Borch K, Jonsson KA, Petersson F, Redeen S, Mardh S, Franzen LE. Prevalence of gastroduodenitis and Helicobacter pylori infection in a general population sample: relations to symptomatology and life-style. Dig Dis Sci 2000;45:1322-9.
28. Malekzadeh R, Sotoudeh M, Derakhshan MH, et al. Prevalence of gastric precancerous lesions in Ardabil, a high incidence province for gastric adenocarcinoma in the northwest of Iran. J Clin Pathol 2004;57:37-42.
29. Krasinski SD, Russell RM, Samloff IM, et al. Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators. J Am Geriatr Soc 1986;34:800-6.
30. Jacques PF, Hartz SC, McGandy RB, Jacob RA, Russell RM. Vitamin C and blood lipoproteins in an elderly population. Ann N Y Acad Sci 1987;498:100-9.
31. Burr ML, Samloff IM, Bates CJ, Holliday RM. Atrophic gastritis and vitamin C status in two towns with different stomach cancer death-rates. Br J Cancer 1987;56:163-7.
32. Palli D, Decarli A, Cipriani F, et al. Plasma pepsinogens, nutrients, and diet in areas of Italy at varying gastric cancer risk. Cancer Epidemiol Biomarkers Prev 1991;1:45-50.
33. Fukao A, Hisamichi S, Ohsato N, Fujino N, Endo N, Iha M. Correlation between the prevalence of gastritis and gastric cancer in Japan. Cancer Causes Control 1993;4:17-20.
34. Fukao A, Komatsu S, Tsubono Y, et al. Helicobacter pylori infection and chronic atrophic gastritis among Japanese blood donors: a cross-sectional study. Cancer Causes Control 1993;4:307-12.
35. Tsugane S, Kabuto M, Imai H, et al. Helicobacter pylori, dietary factors, and atrophic gastritis in five Japanese populations with different gastric cancer mortality. Cancer Causes Control 1993;4:297-305.
36. Tsugane S, Gey F, Ichinowatari Y, et al. Cross-sectional epidemiologic study for assessing cancer risks at the population level. I. Study design and participation rate. J Epidemiol 1992;2:75-81.
37. Webb PM, Hengels KJ, Moller H, et al. The epidemiology of low serum pepsinogen A levels and an international association with gastric cancer rates. EUROGAST Study Group. Gastroenterology 1994;107:1335-44.
38. Epidemiology of, and risk factors for, Helicobacter pylori infection among 3194 asymptomatic subjects in 17 populations. The EUROGAST Study Group. Gut 1993;34:1672-6.
39. Webb PM, Bates CJ, Palli D, Forman D. Gastric cancer, gastritis and plasma vitamin C: results from an international correlation and cross-sectional study. The Eurogast Study Group. Int J Cancer 1997;73:684-9.
40. Knight T, Greaves S, Wilson A, et al. Variability in serum pepsinogen levels in an asymptomatic population. Eur J Gastroenterol Hepatol 1995;7:647-54.
41. Knight T, Wyatt J, Wilson A, et al. Helicobacter pylori gastritis and serum pepsinogen levels in a healthy population: development of a biomarker strategy for gastric atrophy in high risk groups. Br J Cancer 1996;73:819-24.
42. Schlemper RJ, van der Werf SD, Vandenbroucke JP, Biemond I, Lamers CB. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori. Gut 1995;37:199-204.
43. Aromaa A, Kosunen TU, Knekt P, et al. Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol 1996;144:142-9.
44. Watanabe Y, Ozasa K, Higashi A, et al. Helicobacter pylori infection and atrophic gastritis. A case-control study in a rural town of Japan. J Clin Gastroenterol 1997;25:391-4.
45. Hurwitz A, Brady DA, Schaal SE, Samloff IM, Dedon J, Ruhl CE. Gastric acidity in older adults. JAMA 1997;278:659-62.
46. Varis K, Taylor PR, Sipponen P, et al. Gastric cancer and premalignant lesions in atrophic gastritis: a controlled trial on the effect of supplementation with alpha-tocopherol and beta-carotene. The Helsinki Gastritis Study Group. Scand J Gastroenterol 1998;33:294-300.
47. van Asselt DZ, de Groot LC, van Staveren WA, et al. Role of cobalamin intake and atrophic gastritis in mild cobalamin deficiency in older Dutch subjects. Am J Clin Nutr 1998;68:328-34.
48. Tsugane S, Fahey MT, Hamada GS, Kabuto M, Miyakawa VY. Helicobacter pylori infection and atrophic gastritis in middle-aged Japanese residents of Sao Paulo and Lima. Int J Epidemiol 1999;28:577-82.
49. Kuwahara Y, Kono S, Eguchi H, Hamada H, Shinchi K, Imanishi K. Relationship between serologically diagnosed chronic atrophic gastritis, Helicobacter pylori, and environmental factors in Japanese men. Scand J Gastroenterol 2000;35:476-81.
50. Namekata T, Miki K, Kimmey M, et al. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle. Am J Epidemiol 2000;151:820-30.
51. Shibata K, Moriyama M, Fukushima T, Kaetsu A, Miyazaki M, Une H. Green tea consumption and chronic atrophic gastritis: a cross-sectional study in a green tea production village. J Epidemiol 2000;10:310-6.
52. Ito Y, Suzuki K, Ichino N, et al. The risk of Helicobacter Pylori infection and atrophic gastritis from food and drink intake: a cross-sectional study in Hokkaido, Japan. Asian Pac J Cancer Prev 2000;1:147-56.
53. Shibata K, Moriyama M, Fukushima T, Une H, Miyazaki M, Yamaguchi N. Relation of Helicobacter pylori infection and lifestyle to the risk of chronic atrophic gastritis: a cross-sectional study in Japan. J Epidemiol 2002;12:105-11.
54. Sipponen P, Laxen F, Huotari K, Harkonen M. Prevalence of low vitamin B12 and high homocysteine in serum in an elderly male population: association with atrophic gastritis and Helicobacter pylori infection. Scand J Gastroenterol 2003;38:1209-16.
55. Kobayashi T, Kikuchi S, Lin Y, et al. Trends in the incidence of gastric cancer in Japan and their associations with Helicobacter pylori infection and gastric mucosal atrophy. Gastric Cancer 2004;7:233-9.
56. Ohata H, Kitauchi S, Yoshimura N, et al. Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer. Int J Cancer 2004;109:138-43.
57. Sato K, Kawakami N, Ohtsu T, et al. Broccoli consumption and chronic atrophic gastritis among Japanese males: an epidemiological investigation. Acta Med Okayama 2004;58:127-33.
58. Kikuchi S, Yagyu K, Obata Y, et al. Serum pepsinogen values and Helicobacter pylori status among control subjects of a nested case-control study in the JACC study. J Epidemiol 2005;15 Suppl 2:5126-33.
59. Green TJ, Venn BJ, Skeaff CM, Williams SM. Serum vitamin B12 concentrations and atrophic gastritis in older New Zealanders. Eur J Clin Nutr 2005;59:205-10.
60. Aoki K, Kihaile PE, Wenyuan Z, et al. Comparison of prevalence of chronic atrophic gastritis in Japan, China, Tanzania, and the Dominican Republic. Ann Epidemiol 2005;15:598-606.
61. Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M. Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer 1985;35:173-7.
62. Sipponen P. Helicobacter pylori gastritis: epidemiology. J Gastroenterol 1997;32:273-7.
63. Zhang L, Blot WJ, You WC, et al. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population. Cancer Epidemiol Biomarkers Prev 1996;5:627-30.
64. Parkin DM. International variation. Oncogene 2004;23:6329-40.
65. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
66. Varis K, Samloff IM, Ihamaki T, Siurala M. An appraisal of tests for severe atrophic gastritis in relatives of patients with pernicious anemia. Dig Dis Sci 1979;24:187-91.
67. Isokoski M. Screening for atrophie gastritis. Comparison of the results of azure-A test and uropepsin determination with gastric biopsy in a rural population. Scand J Gastroenterol 1969;4:425-33.
68. Haenszel W, Correa P, Lopez A, et al. Serum micronutrient levels in relation to gastric pathology. Int J Cancer 1985;36:43-8.
69. Price AB. The Sydney System: histological division. J Gastroenterol Hepatol 1991;6:209-22.
70. Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161-81.
71. Misiewicz JJ. The Sydney System: a new classification of gastritis. Introduction. J Gastroenterol Hepatol 1991;6:207-8.
72. Whitehead R, Truelove SC, Gear MW. The histological diagnosis of chronic gastritis in fibreoptic gastroscope biopsy specimens. J Clin Pathol 1972;25:1-11.
73. Whitehead R. Mucosal biopsy of the gastrointestinal tract. London: Saunders; 1973.
74. Valencia-Parparcen J, d' Escrivan G, De Gonzáles M. La gastritis como precursora del cancér gastrico y otras enfermedades del estómago. G.E.N. 1970;3:253-69.
75. Correa P. Chronic gastritis: a clinico-pathological classification. Am J Gastroenterol 1988;83:504-9.
76. Correa P, Cuello C, Duque E, et al. Gastric cancer in Colombia. III. Natural history of precursor lesions. J Natl Cancer Inst 1976;57:1027-35.
77. Cheli R, Dodero M, Celle G. [Bioptic findings and secretory behavior of the gastric mucosa in duodenal ulcer: comparison between fundal glandular morphology and the secretory behavior]. Minerva Gastroenterol 1959;5:60-7.
78. Owen DA. The diagnosis and significance of gastritis. Pathol Annu 1979;141 Pt:247-71.
79. Kimura K. Chronological transition of the fundic-pyloric border determined by stepwise biopsy of the lesser and greater curvatures of the stomach. Gastroenterology 1972;63:584-92.
80. Satoh K, Kimura K, Taniguchi Y, et al. Biopsy sites suitable for the diagnosis of Helicobacter pylori infection and the assessment of the extent of atrophic gastritis. Am J Gastroenterol 1998;93:569-73.
81. Offerhaus GJ, Price AB, Haot J, et al. Observer agreement on the grading of gastric atrophy. Histopathology 1999;34:320-5.
82. Cassaro M, Di Mario F, Leandro G, Genta RM, Rugge M. The dark side of the gastric biopsy. Hum Pathol 1999;30:741-4.
83. Genta RM. Recognizing atrophy: another step toward a classification of gastritis. Am J Surg Pathol 1996;20 Suppl 1:S23-30.
84. Genta RM. Review article: gastric atrophy and atrophic gastritis-nebulous concepts in search of a definition. Aliment Pharmacol Ther 1998;12 Suppl 1:17-23.
85. Rugge M, Correa P, Dixon MF, et al. Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading. Aliment Pharmacol Ther 2002;16:1249-59.
86. Plummer M, Buiatti E, Lopez G, et al. Histological diagnosis of precancerous lesions of the stomach: a reliability study. Int J Epidemiol 1997;26:716-20.
87. el-Zimaity HM, Graham DY, al-Assi MT, et al. Interobserver variation in the histopathological assessment of Helicobacter pylori gastritis. Hum Pathol 1996;27:35-41.
88. Andrew A, Wyatt JI, Dixon MF. Observer variation in the assessment of chronic gastritis according to the Sydney system. Histopathology 1994;25:317-22.
89. Chen XY, van der Hulst RW, Bruno MJ, et al. Interobserver variation in the histopathological scoring of Helicobacter pylori related gastritis. J Clin Pathol 1999;52:612-5.
90. Guarner J, Herrera-Goepfert R, Mohar A, et al. Interobserver variability in application of the revised Sydney classification for gastritis. Hum Pathol 1999;30:1431-4.
91. Rugge M, Genta RM. Staging and grading of chronic gastritis. Hum Pathol 2005;36:228-33.
92. Ruiz B, Garay J, Johnson W, et al. Morphometric assessment of gastric antral atrophy: comparison with visual evaluation. Histopathology 2001;39:235-42.
93. Miki K, Morita M, Sasajima M, Hoshina R, Kanda E, Urita Y. Usefulness of gastric cancer screening using the serum pepsinogen test method. Am J Gastroenterol 2003;98:735-9.
94. Kurosawa M, Kikuchi S, Arisue T, Fukao A. [Effectiveness and feasibility of a strategy for increasing participation in the Japanese Stomach Cancer Examination programs by incorporating serum pepsinogen tests]. Nippon Koshu Eisei Zasshi 1998;45:352-60.
95. Miki K, Ichinose M, Shimizu A, et al. Serum pepsinogens as a screening test of extensive chronic gastritis. Gastroenterol Jpn 1987;22:133-41.
96. Miki K, Ichinose M, Kawamura N, et al. The significance of low serum pepsinogen levels to detect stomach cancer associated with extensive chronic gastritis in Japanese subjects. Jpn J Cancer Res 1989;80:111-4.
97. Kikuchi S, Inaba Y, Wada O, et al. The association of smoking and drinking habits with serum pepsinogens. Int J Epidemiol 1995;24:346-53.
98. Tatemichi M, Kabuto M, Tsugane S. Effect of smoking on serum pepsinogen I level depends on serological status of Helicobacter pylori. Jpn J Cancer Res 2001;92:243-8.
99. Veenendaal RA, Biemond I, Pena AS, van Duijn W, Kreuning J, Lamers CB. Influence of age and Helicobacter pylori infection on serum pepsinogens in healthy blood transfusion donors. Gut 1992;33:452-5.